vs
Side-by-side financial comparison of Prenetics Global Ltd (PRE) and Seer, Inc. (SEER). Click either name above to swap in a different company.
Prenetics Global Ltd is the larger business by last-quarter revenue ($4.3M vs $4.2M, roughly 1.0× Seer, Inc.).
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
PRE vs SEER — Head-to-Head
Income Statement — Q3 2023 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $4.3M | $4.2M |
| Net Profit | — | $-16.0M |
| Gross Margin | 44.9% | 52.0% |
| Operating Margin | -396.2% | -413.8% |
| Net Margin | — | -380.7% |
| Revenue YoY | — | 5.0% |
| Net Profit YoY | — | 26.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.2M | ||
| Q3 25 | — | $4.1M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $4.2M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | — | $3.1M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | — | $-18.2M | ||
| Q2 25 | — | $-19.4M | ||
| Q1 25 | — | $-19.9M | ||
| Q4 24 | — | $-21.7M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-22.9M | ||
| Q1 24 | — | $-20.7M |
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | 51.2% | ||
| Q2 25 | — | 52.1% | ||
| Q1 25 | — | 49.0% | ||
| Q4 24 | — | 50.6% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 56.3% | ||
| Q1 24 | — | 44.4% |
| Q4 25 | — | -413.8% | ||
| Q3 25 | — | -469.4% | ||
| Q2 25 | — | -506.8% | ||
| Q1 25 | — | -493.0% | ||
| Q4 24 | — | -587.2% | ||
| Q3 24 | — | -603.3% | ||
| Q2 24 | — | -882.0% | ||
| Q1 24 | — | -821.7% |
| Q4 25 | — | -380.7% | ||
| Q3 25 | — | -442.5% | ||
| Q2 25 | — | -479.5% | ||
| Q1 25 | — | -474.4% | ||
| Q4 24 | — | -543.6% | ||
| Q3 24 | — | -529.0% | ||
| Q2 24 | — | -743.8% | ||
| Q1 24 | — | -674.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $-0.35 | ||
| Q1 24 | — | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $259.3M |
| Total Assets | — | $296.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $47.3M | ||
| Q3 25 | — | $45.0M | ||
| Q2 25 | — | $37.9M | ||
| Q1 25 | — | $52.4M | ||
| Q4 24 | — | $40.8M | ||
| Q3 24 | — | $37.6M | ||
| Q2 24 | — | $31.9M | ||
| Q1 24 | — | $54.4M |
| Q4 25 | — | $259.3M | ||
| Q3 25 | — | $271.8M | ||
| Q2 25 | — | $288.3M | ||
| Q1 25 | — | $311.0M | ||
| Q4 24 | — | $327.6M | ||
| Q3 24 | — | $344.7M | ||
| Q2 24 | — | $364.7M | ||
| Q1 24 | — | $383.6M |
| Q4 25 | — | $296.1M | ||
| Q3 25 | — | $308.6M | ||
| Q2 25 | — | $322.5M | ||
| Q1 25 | — | $347.3M | ||
| Q4 24 | — | $366.6M | ||
| Q3 24 | — | $383.4M | ||
| Q2 24 | — | $406.6M | ||
| Q1 24 | — | $422.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-10.8M |
| Free Cash FlowOCF − Capex | — | $-11.1M |
| FCF MarginFCF / Revenue | — | -264.2% |
| Capex IntensityCapex / Revenue | — | 7.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-46.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-10.8M | ||
| Q3 25 | — | $-7.6M | ||
| Q2 25 | — | $-14.7M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | — | $-11.5M | ||
| Q3 24 | — | $-14.1M | ||
| Q2 24 | — | $-10.1M | ||
| Q1 24 | — | $-10.5M |
| Q4 25 | — | $-11.1M | ||
| Q3 25 | — | $-7.8M | ||
| Q2 25 | — | $-15.2M | ||
| Q1 25 | — | $-12.1M | ||
| Q4 24 | — | $-12.0M | ||
| Q3 24 | — | $-16.3M | ||
| Q2 24 | — | $-11.2M | ||
| Q1 24 | — | $-11.2M |
| Q4 25 | — | -264.2% | ||
| Q3 25 | — | -190.5% | ||
| Q2 25 | — | -375.9% | ||
| Q1 25 | — | -287.1% | ||
| Q4 24 | — | -299.8% | ||
| Q3 24 | — | -404.7% | ||
| Q2 24 | — | -366.0% | ||
| Q1 24 | — | -365.6% |
| Q4 25 | — | 7.0% | ||
| Q3 25 | — | 6.9% | ||
| Q2 25 | — | 14.0% | ||
| Q1 25 | — | 15.6% | ||
| Q4 24 | — | 13.4% | ||
| Q3 24 | — | 54.4% | ||
| Q2 24 | — | 38.2% | ||
| Q1 24 | — | 24.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
